Income Taxes	9 Months Ended
Sep. 30, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company's quarterly tax provision is measured using an estimated annual effective tax rate, adjusted for discrete items within the periods presented. The comparison of the Company's effective tax rate between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction, foreign income tax rate differentials and discrete items. For the three months ended September 30, 2017 and 2016, income tax expense totaled $37.5 million and $20.4 million, respectively. The difference between the U.S. statutory rate and effective tax rate for the three months ended September 30, 2017 and 2016 primarily related to the recognition of valuation allowances on net operating losses that may not be recoverable for U.S. and foreign companies. In addition, for the three months ended September 30, 2016, the Company recognized a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta Acquisition and a $15.3 million benefit related to the recognition of tax deductible goodwill, offset by a $14.7 million charge related to tax on foreign operations. For the nine months ended September 30, 2017 and 2016, income tax expense totaled $67.3 million and $65.7 million, respectively. The difference between the U.S. statutory rate and effective tax rate for the nine months ended September 30, 2017 and 2016 primarily related to the recognition of valuation allowances on net operating losses that may not be recoverable for U.S. and foreign companies. In addition, for the nine months ended September 30, 2016, the Company recognized a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta Acquisition and a $15.3 million benefit related to the recognition of tax deductible goodwill, offset by a $10.0 million charge related to tax on foreign operations.

INCOME TAXES

The Company's quarterly tax provision is measured using an estimated annual effective tax rate, adjusted for discrete items within the periods presented. The comparison of the Company's effective tax rate between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction, foreign income tax rate differentials and discrete items.

For the three months ended September 30, 2017 and 2016, income tax expense totaled $37.5 million and $20.4 million, respectively. The difference between the U.S. statutory rate and effective tax rate for the three months ended September 30, 2017 and 2016 primarily related to the recognition of valuation allowances on net operating losses that may not be recoverable for U.S. and foreign companies. In addition, for the three months ended September 30, 2016, the Company recognized a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta Acquisition and a $15.3 million benefit related to the recognition of tax deductible goodwill, offset by a $14.7 million charge related to tax on foreign operations.

For the nine months ended September 30, 2017 and 2016, income tax expense totaled $67.3 million and $65.7 million, respectively. The difference between the U.S. statutory rate and effective tax rate for the nine months ended September 30, 2017 and 2016 primarily related to the recognition of valuation allowances on net operating losses that may not be recoverable for U.S. and foreign companies. In addition, for the nine months ended September 30, 2016, the Company recognized a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta Acquisition and a $15.3 million benefit related to the recognition of tax deductible goodwill, offset by a $10.0 million charge related to tax on foreign operations.